Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical relevance of inhaled corticosteroids and HPA axis suppression

Published byGro Amundsen Modified over 5 years ago

Similar presentations

Presentation on theme: "Clinical relevance of inhaled corticosteroids and HPA axis suppression"— Presentation transcript:

1 Clinical relevance of inhaled corticosteroids and HPA axis suppression
Robert G. Dluhy, MD  Journal of Allergy and Clinical Immunology  Volume 101, Issue 4, Pages S447-S450 (April 1998) DOI: /S (98) Copyright © 1998 Mosby, Inc. Terms and Conditions

2 Fig. 1 Effect of budesonide (800 μg once daily),placebo, and fluticasone propionate (>FP; 250, 500, and 1000 μg once daily; 1000 μg twice daily) on 8-hour plasma cortisol levels in healthy volunteers. Reproduced with permission from Grahnen A. Eckermas SA, Brundin RM, Ling-Anderson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 1994;38:521-5, by Blackwell Science Ltd.). Journal of Allergy and Clinical Immunology  , S447-S450DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

3 Fig. 2 Effect of placebo, fluticasone propionate (FP; 100 and 500 μg twice daily), triamcinolone acetonide (TAA; 300 and 500 μg twice daily), and prednisone (Pred; 10 mg daily) on plasma cortisol levels in asthma patients (data on file, Glaxo Wellcome). Journal of Allergy and Clinical Immunology  , S447-S450DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

Download ppt "Clinical relevance of inhaled corticosteroids and HPA axis suppression"

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered- dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder.

Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered- dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder.
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Shin-Ichi Nishikawa, MD, PhD 

Shin-Ichi Nishikawa, MD, PhD 
David B Allen, MD  Journal of Allergy and Clinical Immunology 

David B Allen, MD  Journal of Allergy and Clinical Immunology 
Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations  Peter G. Gibson, MBBS(Hons),

Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations  Peter G. Gibson, MBBS(Hons),
Christine A. Sorkness, PharmD 

Christine A. Sorkness, PharmD 
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis  William R. Lumry, MD  Journal of.

A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis  William R. Lumry, MD  Journal of.
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Asthma diagnosis and treatment: Filling in the information gaps

Asthma diagnosis and treatment: Filling in the information gaps
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.

Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Practice Notes from the AAAI

Practice Notes from the AAAI
David P. Skoner, MD, Betty L

David P. Skoner, MD, Betty L
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,

Similar presentations

Ads by Google